Tocilizumab for steroid refractory acute graft-versus-host disease

Acute graft-versus-host-disease (aGVHD) is a frequent and often lethal complication of allogeneic hematopoietic stem cell transplant despite prophylaxis. Tocilizumab is a humanized anti-IL-6 receptor monoclonal antibody that has evidence of activity in patients with steroid refractory (SR) GVHD. We...

全面介紹

Na minha lista:
書目詳細資料
發表在:Leuk Lymphoma
Main Authors: Roddy, Julianna V. F., Haverkos, Bradley M., McBride, Ali, Leininger, Kathryn M., Jaglowski, Samantha, Penza, Sam, Klisovic, Rebecca, Blum, William, Vasu, Sumithira, Hofmeister, Craig C., Benson, Don M., Andritsos, Leslie A., Devine, Steven M., Efebera, Yvonne A.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698359/
https://ncbi.nlm.nih.gov/pubmed/26140610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1045896
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍